quick question....could you use Long R3 IGF-1 with clomid in a PCT. Want something to keep me hard and not lose much of my gains...btw can't seem to find any proviron which i heard works well.....any advice???
Printable View
quick question....could you use Long R3 IGF-1 with clomid in a PCT. Want something to keep me hard and not lose much of my gains...btw can't seem to find any proviron which i heard works well.....any advice???
The IGF will work fine with clomid during pct. Many people feel that it brings your nuts back to full size better than clomid, and there are several medical studies out there that prove how well it brings your nuts back.
As far as the proviron maybe Mick-G can chime in here. I used proviron HCG and clomid for pct the way that he reccomended and it worked great.
Proviron is best. It will raise your natural test levels and get your libido back. I just got off cycle last Monday doing 3,000IU HCG split 3 times a wk for 2 wks with proviron 25mg ed. This Monday i will start pct with clomid and proviron 50mg ed for 28 days. I have heard ppl using igf which maybe good, but im looking at it as more of a getting yourself back to a normal testicular function,free test and gains, rather then using igf to retain gains and keeping bf down. Actually, it would prob be nice to do both, lol!, but proviron is becomming standard part of pct.
Here's a good read on PROVIRON....
Int J Gynaecol Obstet 1988 Feb;26(1):121-8 Related Articles, Links
The effect of mesterolone on sperm count, on serum follicle stimulating hormone, luteinizing hormone, plasma testosterone and outcome in idiopathic oligospermic men.
Varma TR, Patel RH.
Department of Obstetrics & Gynaecology, St. George's Hospital Medical School London, U.K.
Two hundred fifty subfertile men with idiopathic oligospermia (count less than 20 million/ml) were treated with mesterolone (100-150 mg/day) for 12 months. Seminal analysis were assayed 3 times and serum follicle stimulating hormone (FSH) luteinizing hormone (LH) and plasma testosterone were assayed once before treatment and repeated at 3, 6, 9 and 12 months after the initiation of treatment. One hundred ten patients (44%) had normal serum FSH, LH and plasma testosterone, 85 patients (34%) had low serum FSH, LH and low plasma testosterone. One hundred seventy-five patients (70%) had moderate oligospermia (count 5 to less than 20 million/ml) and 75 patients (30%) had severe oligospermia (count less than 5 million/ml). Seventy-five moderately oligospermic patients showed significant improvement in the sperm density, total sperm count and motility following mesterolone therapy whereas only 12% showed improvement in the severe oligospermic group. Mesterolone had no depressing effect on low or normal serum FSH and LH levels but had depressing effect on 25% if the levels were elevated. There was no significant adverse effect on testosterone levels or on liver function. One hundred fifteen (46%) pregnancies resulted following the treatment, 9 of 115 (7.8%) aborted and 2 (1.7%) had ectopic pregnancy. Mesterolone was found to be more useful in patients with a sperm count ranging between 5 and 20 million/ml. Those with severe oligospermia (count less than 5 million) do not seem to benefit from this therapy.
PMID: 2892728 [PubMed - indexed for MEDLINE]